Biomarkers · Chemical
We have not added a physiological summary for this biomarker yet. Compare the commercial laboratory assays and population reference ranges below.
Check orderable catalog codes, specimen types, fasting requirements, and demographic reference ranges across laboratories.
Laboratory assay overview
This test is used for treatment and management of known or suspected kidney stone formers.
Labcorp test directory, test code 910235
Laboratory assay overview
Useful in the assessment of nutritional and metabolic disorder. Increased levels indicate renal and respiratory failure and decreased levels indicate seizures, tetany, cardiac arrhythmias, Low CA++ and K+.
Quest Diagnostics population reference ranges
Quest Diagnostics calculates these statistical intervals for this specific assay and demographic group, not as universal optimal targets.
| Population | Range |
|---|---|
| Male | 28-180 mg/24 h |
| Female | 18-130 mg/24 h |
Magnesium, 24-Hour Urine Male 28-180 mg/24 h Female 18-130 mg/24 h
Quest Diagnostics test directory, test code 11322
Laboratory assay overview
Magnesium excretion controls magnesium balance.1 Magnesium urinary excretion is enhanced by increasing blood alcohol levels, diuretics, Bartter syndrome, corticosteroids, cis-platinum therapy and aldosterone. Renal magnesium wasting occurs in renal transplant recipients who are on cyclosporine and prednisone.2 Renal conservation of magnesium is diminished by hypercalciuria, salt-losing conditions, and the syndrome of inappropriate secretion of antidiuretic hormone.1 Magnesium deficiency is often inadequately documented by serum magnesium levels. Urinary magnesium analyses have been advocated before and after therapeutic magnesium administration to further investigate the significance of an apparent low serum magnesium.3
Environmental exposure: 12.0−293.0 mg/24 hours
Labcorp test directory, test code 003400
Laboratory assay overview
StoneRisk® Panel is for stone formers with a positive urine culture indicating urinary tract infection (UTI), also for recurrent stone formers or when attending physician deems it medically necessary for the patient to have comprehensive metabolic evaluation.
See Laboratory Report
Quest Diagnostics test directory, test code 442
Laboratory assay overview
UroRisk® Panel is recommended for initial and recurrent stone formers (excluding patients with Struvite stones).
See Laboratory Report
Quest Diagnostics test directory, test code 15565
We compile every detail above directly from named laboratory directories and published clinical studies. Laboratories calculate standard reference intervals from the statistical distribution of tested populations for a specific assay method and demographic group, rather than setting universal optimal targets.
Always review your personal lab results with a licensed clinician, or track your lab history and health goals in Aumnivida.
Spotted an error? Email hello@biomarkerlens.com with the page URL and the primary source that corrects the entry.